VAERS 2289159
SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ464AB
- Staat
- DC
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 06.12.2021
- Beginn
- 06.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RL
Symptomtext
administration of PENTACEL without the Hib component, got the liquid component of PENTACEL without the lyophilized component with no reported adverse event; Initial information received on 12-May-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 2 years old female patient who experienced administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel] without the hib component, got the liquid component of pentacel without the lyophilized component with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine conj 7v (crm197) (Prevnar) for prophylactic vaccination; influenza vaccine (influenza) for prophylactic vaccination; and hepatitis a vaccine (hepatitis a) for Prophylactic vaccination. On 06-Dec-2021, the patient received a 4 dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine Suspension for injection at a dose of 0.5 ml total (lot UJ464AB; expiry date: 21-May-2022;, strength unknown) via intramuscular route in the right thigh as Immunization. On 06-DEC-2021, the diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine without the hib component, got the liquid component of diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) without the lyophilized component with no reported adverse event (single component of a two-component product administered) (latency: same day). It was reported that she would like to know if she should start over the whole dose or if she could reconstitute the powder with something else and administer it. Action taken: not applicable. At time of reporting, the outcome was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -